2-naphthol has been researched along with Parkinsonian Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biswas, S; Dutta, AK; Fernandez, F; Ghosh, B; Kuzhikandathil, E; Reith, ME; Zhang, S; Zhen, J | 1 |
1 other study(ies) available for 2-naphthol and Parkinsonian Disorders
| Article | Year |
|---|---|
Further structure-activity relationships study of hybrid 7-{[2-(4-phenylpiperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol analogues: identification of a high-affinity D3-preferring agonist with potent in vivo activity with long duration
Topics: Animals; Antiparkinson Agents; Cell Line; Cricetinae; Cricetulus; Humans; Naphthols; Oxidopamine; Parkinsonian Disorders; Piperazines; Propylamines; Radioligand Assay; Receptors, Dopamine D3; Stereoisomerism; Stereotyped Behavior; Structure-Activity Relationship; Tetrahydronaphthalenes; Time Factors | 2008 |